Total Funding
46
62
Total FundingPost-IPO Equity raised
Growth Score
-6 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
113635
Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.
- Amro Albanna: Co-founder, Chairman, and CEOPast Role: ieCrowd, Co-Founder & CEO
- Corinne Pankovcin: President
About the Company
Aditx Therapeutics is a biotechnology company developing a novel nucleic acid-based technology to selectively suppress immune cells involved in the rejection of transplanted tissues and organs. The company was founded in 2017 by Amro Albanna and is based in Loma Linda, California, United States.
